Abstract:Background:The ongoing global coronavirus disease 2019 (COVID-19) pandemic is posing a serious public health threat to nations worldwide. Understanding the pathogenesis of the disease and host immune responses will facilitate the discovery of therapeutic targets and better management of infected patients. Metabolomics technology can provide an unbiased tool to explore metabolic perturbation.Methods:Twenty-six healthy controls and 50 COVID-19 patients with mild, moderate, and severe symptoms in the Fifth Medical Center of PLA General Hospital from January 22 to February 16, 2020 were recruited into the study. Fasting blood samples were collected and subject to metabolomics analysis by liquid chromatography-mass spectrometry. Metabolite abundance was measured by peak area and was log-transformed before statistical analysis. The principal component analysis, different expression analysis, and metabolic pathway analysis were performed using R package. Co-regulated metabolites and their associations with clinical indices were identified by the weighted correlation network analysis and Spearman correlation coefficients. The potential metabolite biomarkers were analyzed using a random forest model.Results:We uncovered over 100 metabolites that were associated with COVID-19 disease and many of them correlated with disease severity. Sets of highly correlated metabolites were identified and their correlations with clinical indices were presented. Further analyses linked the differential metabolites with biochemical reactions, metabolic pathways, and biomedical MeSH terms, offering contextual insights into disease pathogenesis and host responses. Finally, a panel of metabolites was discovered to be able to discriminate COVID-19 patients from healthy controls, and also another list for mild against more severe cases. Our findings showed that in COVID-19 patients, citrate cycle, sphingosine 1-phosphate in sphingolipid metabolism, and steroid hormone biosynthesis were downregulated, while purine metabolism and tryptophan metabolism were disturbed.Conclusion:This study discovered key metabolites as well as their related biological and medical concepts pertaining to COVID-19 pathogenesis and host immune response, which will facilitate the selection of potential biomarkers for prognosis and discovery of therapeutic targets.

Amino acid profiling of COVID-19 patients blood serum

The Serum Metabolome of COVID-19 Patients is Distinctive and Predictive

Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress

Tryptophan and arginine metabolism is significantly altered at the time of admission in hospital for severe COVID-19 patients: findings from longitudinal targeted metabolomics analysis

Metabolomic profiling of COVID-19 using serum and urine samples in intensive care and medical ward cohorts

Quantitative LC-MS study of compounds found predictive of COVID-19 severity and outcome

Proteomic blood profiling in mild, severe and critical COVID-19 patients

Investigation of Urine Organic Acid Profile in Coronavirus Disease (COVID-19) Patients

Targeted MRM-analysis of plasma proteins in frozen whole blood samples from patients with COVID-19: a retrospective study

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

Evaluation of serum and urine biomarkers for severe COVID-19

Molecular fingerprint by omics-based approaches in saliva from patients affected by SARS-CoV-2 infection

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19

Systematic Discovery and Pathway Analyses of Metabolic Disturbance in COVID-19

Identification of critical SARS-CoV-2 amino acids associated with COVID-19 hospitalization rate using machine learning and statistical modeling: An observational study in the United States

Metabolomic alterations in the plasma of patients with various clinical manifestations of COVID-19

Metabolic and immune markers for precise monitoring of COVID-19 severity and treatment

Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19

Analysis of the Urine Volatilome of COVID-19 Patients and the Possible Metabolic Alterations Produced by the Disease

Sulfated Bile Acids in Serum as Potential Biomarkers of Disease Severity and Mortality in COVID-19

Metabolomic Insights into COVID-19 Severity: A Scoping Review